» Articles » PMID: 35834057

Sex-Dependent Alterations in the MRNA Expression of Enzymes Involved in Dopamine Synthesis and Breakdown After Methamphetamine Self-Administration

Overview
Journal Neurotox Res
Publisher Springer
Specialty Neurology
Date 2022 Jul 14
PMID 35834057
Authors
Affiliations
Soon will be listed here.
Abstract

Sex differences have been reported in methamphetamine (METH) use disorder in humans and in animal models of METH exposure. Specifically, animals that self-administer METH show sex-related dissimilarities in dopamine (DA) metabolism. To better understand the molecular bases for the differences in DA metabolism, we measured the levels of mRNAs of enzymes that catalyze DA synthesis and breakdown in the prefrontal cortex (PFC), nucleus accumbens (NAc), dorsal striatum (dSTR), and hippocampus (HIP) of rats that had self-administered METH. There were significant sex differences in control rats, with males having higher basal levels of Th in the PFC and dSTR, Ddc in the NAc, and MaoB in the HIP. In contrast, female controls showed higher basal levels of Comt in the HIP. Male and female METH SA rats also showed some distinct responses to the drug. Specifically, female METH rats exhibited increased expression of Ddc and MaoB, whereas male METH animals showed higher levels of Comt mRNA in the PFC compared to their respective controls. In the NAc, male METH rats displayed decreased Th and Ddc mRNA levels. Together, our results identified sex-dependent and region-specific changes in the mRNA expression of several enzymes involved in DA synthesis and breakdown in response to METH SA, with the majority of differences being observed in the mesocorticolimbic dopaminergic system. These findings are of significant translational importance providing further support for the inclusion of sex as an important variable when planning and evaluating therapeutic interventions against METH use disorder in human clinical studies.

Citing Articles

The estrous cycle has no effect on incubation of methamphetamine craving and associated Fos expression in dorsomedial striatum and anterior intralaminar nucleus of thalamus.

Lin H, Olaniran A, Garmchi S, Firlie J, Rincon N, Li X Addict Neurosci. 2024; 11.

PMID: 38938268 PMC: 11210321. DOI: 10.1016/j.addicn.2024.100158.


Modeling methamphetamine use disorder in mammals: Sex differences in behavioral, biochemical, and transcriptional consequences.

Daiwile A, Cadet J Adv Pharmacol. 2024; 99:145-168.

PMID: 38467480 PMC: 11474929. DOI: 10.1016/bs.apha.2023.08.002.


Persistent Neuroadaptations in the Nucleus Accumbens Core Accompany Incubation of Methamphetamine Craving in Male and Female Rats.

Funke J, Hwang E, Wunsch A, Baker R, Engeln K, Murray C eNeuro. 2023; 10(3).

PMID: 36792361 PMC: 10016192. DOI: 10.1523/ENEURO.0480-22.2023.

References
1.
Amalric M, Koob G . Functionally selective neurochemical afferents and efferents of the mesocorticolimbic and nigrostriatal dopamine system. Prog Brain Res. 1993; 99:209-26. DOI: 10.1016/s0079-6123(08)61348-5. View

2.
Bortolato M, Chen K, Shih J . Monoamine oxidase inactivation: from pathophysiology to therapeutics. Adv Drug Deliv Rev. 2008; 60(13-14):1527-33. PMC: 2630537. DOI: 10.1016/j.addr.2008.06.002. View

3.
Bourque M, Dluzen D, Di Paolo T . Sex and temporally-dependent effects of methamphetamine toxicity on dopamine markers and signaling pathways. Neuropharmacology. 2012; 62(7):2363-72. DOI: 10.1016/j.neuropharm.2012.02.009. View

4.
Bourque M, Liu B, Dluzen D, Di Paolo T . Sex differences in methamphetamine toxicity in mice: effect on brain dopamine signaling pathways. Psychoneuroendocrinology. 2011; 36(7):955-69. DOI: 10.1016/j.psyneuen.2010.12.007. View

5.
Cadet J, Krasnova I, Ladenheim B, Cai N, McCoy M, Atianjoh F . Methamphetamine preconditioning: differential protective effects on monoaminergic systems in the rat brain. Neurotox Res. 2009; 15(3):252-9. PMC: 2673017. DOI: 10.1007/s12640-009-9026-0. View